Embecta (EMBC) Financials

$3.90 -5.35 (-57.84%)

Closing price 04:00 PM Eastern

Extended Trading

$4.02 +0.12 (+3.18%)

As of 07:59 PM Eastern

Annual Income Statements for Embecta

This table shows Embecta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	428	415	224	70	78	95
Consolidated Net Income / (Loss)	428	415	224	70	78	95
Net Income / (Loss) Continuing Operations	428	415	224	70	78	95
Total Pre-Tax Income	486	495	257	106	44	136
Total Operating Income	487	492	310	222	167	242
Total Gross Profit	763	800	775	750	735	677
Total Revenue	1,086	1,165	1,130	1,121	1,123	1,080
Operating Revenue	1,086	1,165	1,130	1,121	1,123	1,080
Total Cost of Revenue	323	365	355	371	388	404
Operating Cost of Revenue	323	365	355	371	388	404
Total Operating Expenses	276	308	465	528	568	435
Selling, General & Admin Expense	215	245	340	441	490	397
Research & Development Expense	61	63	67	85	79	37
Impairment Charge	0.00	0.00	59	2.50	0.00	0.00
Total Other Income / (Expense), net	-0.70	2.90	-53	-116	-123	-106
Interest & Investment Income	0.00	0.00	-46	-107	-112	-107
Other Income / (Expense), net	-	2.90	-6.80	-8.80	-10	1.50
Income Tax Expense	58	80	33	35	-34	41
Basic Earnings per Share	$7.50	$7.28	$3.92	$1.23	$1.36	$1.64
Weighted Average Basic Shares Outstanding	-	-	57.07M	57.33M	58.13M	58.51M
Diluted Earnings per Share	$7.50	$7.28	$3.89	$1.22	$1.34	$1.62
Weighted Average Diluted Shares Outstanding	-	-	57.07M	57.33M	58.13M	58.51M
Weighted Average Basic & Diluted Shares Outstanding	-	-	57.07M	57.33M	58.13M	58.51M
Cash Dividends to Common per Share	-	-	$0.15	$0.60	$0.60	$0.60

This table shows Embecta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	14	15	6.00	20	29	15	15	0.00	24	46	26
Consolidated Net Income / (Loss)	14	15	6.00	20	29	15	15	0.00	24	46	26
Net Income / (Loss) Continuing Operations	14	15	6.00	20	29	15	15	0.00	24	46	26
Total Pre-Tax Income	25	20	5.00	14	9.90	27	-7.00	-0.70	36	72	29
Total Operating Income	56	51	26	46	39	56	26	29	63	94	57
Total Gross Profit	190	190	182	186	185	190	174	157	164	197	159
Total Revenue	277	286	282	277	287	273	286	262	259	296	264
Operating Revenue	277	286	282	277	287	273	286	262	259	296	264
Total Cost of Revenue	87	97	100	91	102	82	112	105	95	98	106
Operating Cost of Revenue	87	97	100	91	102	82	112	105	95	98	106
Total Operating Expenses	134	138	156	140	146	134	148	128	101	103	102
Selling, General & Admin Expense	112	116	130	120	128	114	128	108	93	99	97
Research & Development Expense	22	23	24	20	18	20	20	20	8.00	4.40	4.60
Total Other Income / (Expense), net	-31	-31	-21	-31	-29	-29	-33	-29	-27	-22	-28
Interest & Investment Income	-27	-27	-28	-28	-28	-28	-29	-28	-27	-27	-26
Other Income / (Expense), net	-4.30	-4.20	6.80	-3.50	-1.50	-1.10	-4.20	-1.50	-0.40	4.80	-1.40
Income Tax Expense	11	4.90	-1.00	-5.80	-19	12	-22	-0.70	12	27	2.60
Basic Earnings per Share	$0.24	$0.27	$0.10	$0.35	$0.50	$0.25	$0.26	$0.00	$0.40	$0.78	$0.46
Weighted Average Basic Shares Outstanding	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M	58.49M	58.51M
Diluted Earnings per Share	$0.24	$0.26	$0.11	$0.35	$0.50	$0.25	$0.24	$0.00	$0.40	$0.78	$0.44
Weighted Average Diluted Shares Outstanding	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M	58.49M	58.51M
Weighted Average Basic & Diluted Shares Outstanding	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M	58.49M	58.51M

This table details how cash moves in and out of Embecta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	0.00	0.00	331	-4.40	-52	-46
Net Cash From Operating Activities	499	456	412	68	36	192
Net Cash From Continuing Operating Activities	499	456	412	68	36	192
Net Income / (Loss) Continuing Operations	428	415	224	70	78	95
Consolidated Net Income / (Loss)	428	415	224	70	78	95
Depreciation Expense	38	38	32	33	36	41
Amortization Expense	0.00	0.00	3.20	6.40	13	20
Non-Cash Adjustments To Reconcile Net Income	22	27	31	0.80	85	68
Changes in Operating Assets and Liabilities, net	11	-23	123	-43	-177	-31
Net Cash From Investing Activities	-42	-39	-24	-27	-16	-9.30
Net Cash From Continuing Investing Activities	-42	-39	-24	-27	-16	-9.30
Purchase of Property, Plant & Equipment	-42	-37	-24	-27	-16	-9.30
Net Cash From Financing Activities	-457	-417	-48	-49	-73	-227
Net Cash From Continuing Financing Activities	-457	-417	-48	-49	-73	-227
Repayment of Debt	0.00	0.00	-44	-9.50	-35	-185
Payment of Dividends	0.00	0.00	-8.60	-34	-35	-35
Other Financing Activities, net	-457	-417	-1,446	-4.80	-4.30	-7.10
Effect of Exchange Rate Changes	0.00	0.00	-9.30	3.10	1.20	-1.30

This table details how cash moves in and out of Embecta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Net Change in Cash & Equivalents	-39	-29	9.10	-28	7.80	-25	-7.60	-58	-4.40	21	-5.00
Net Cash From Operating Activities	-13	-9.30	30	-13	24	-2.10	27	-5.30	32	81	84
Net Cash From Continuing Operating Activities	-13	-9.30	30	-13	24	-2.10	27	-5.30	32	81	84
Net Income / (Loss) Continuing Operations	14	15	6.00	20	29	15	15	0.00	24	46	26
Consolidated Net Income / (Loss)	14	15	6.00	20	29	15	15	0.00	24	46	26
Depreciation Expense	8.00	8.10	9.30	8.80	9.00	8.90	9.50	9.40	9.00	9.20	13
Amortization Expense	1.60	1.60	1.60	2.00	2.80	3.80	4.60	4.60	4.70	5.00	5.20
Non-Cash Adjustments To Reconcile Net Income	0.20	-34	39	24	54	-8.80	16	35	6.80	11	15
Changes in Operating Assets and Liabilities, net	-37	0.20	-26	-68	-70	-21	-18	-54	-12	11	24
Net Cash From Investing Activities	-5.80	-6.80	-9.20	-2.70	-3.40	-9.70	-	-1.50	-0.10	-0.40	-7.30
Net Cash From Continuing Investing Activities	-5.80	-6.80	-9.20	-2.70	-3.40	-9.70	-	-1.50	-0.10	-0.40	-7.30
Purchase of Property, Plant & Equipment	-5.80	-6.80	-9.20	-2.70	-3.40	-9.70	-	-1.50	-0.10	-0.40	-7.30
Net Cash From Financing Activities	-21	-12	-9.70	-14	-12	-12	-37	-45	-37	-63	-82
Net Cash From Continuing Financing Activities	-21	-12	-9.70	-14	-12	-12	-37	-45	-37	-63	-82
Repayment of Debt	-2.40	-2.30	-2.40	-2.40	-2.40	-2.40	-27	-32	-27	-52	-72
Payment of Dividends	-17	-8.60	-8.60	-8.60	-8.60	-8.60	-8.70	-8.80	-8.70	-8.70	-8.80
Other Financing Activities, net	-1.10	-1.30	1.30	-2.50	-0.80	-0.50	-0.50	-4.00	-1.20	-1.50	-0.40
Effect of Exchange Rate Changes	0.70	-0.70	-1.60	1.50	-1.30	-1.40	2.40	-5.50	1.20	3.10	-0.10

This table presents Embecta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	788	1,086	1,214	1,285	1,091
Total Current Assets	292	665	749	761	631
Cash & Equivalents	0.00	331	326	268	226
Restricted Cash	-	-	0.20	6.70	3.10
Accounts Receivable	151	133	159	247	149
Inventories, net	118	123	152	172	179
Other Current Assets	23	78	111	69	75
Plant, Property, & Equipment, net	451	302	300	290	257
Total Noncurrent Assets	45	120	165	234	202
Goodwill	34	25	25	24	22
Noncurrent Deferred & Refundable Income Taxes	11	96	140	210	180
Total Liabilities & Shareholders' Equity	788	1,086	1,214	1,285	1,091
Total Liabilities	194	1,978	2,036	2,024	1,742
Total Current Liabilities	164	301	354	374	262
Short-Term Debt	0.00	9.50	9.50	9.50	9.50
Accounts Payable	54	108	127	134	91
Accrued Expenses	82	104	118	134	99
Current Deferred & Payable Income Tax Liabilities	0.00	27	34	27	9.80
Current Employee Benefit Liabilities	28	49	62	67	49
Other Current Liabilities	0.00	3.60	3.60	3.40	3.40
Total Noncurrent Liabilities	30	1,677	1,683	1,650	1,480
Long-Term Debt	0.00	1,598	1,594	1,565	1,389
Noncurrent Deferred & Payable Income Tax Liabilities	30	46	57	54	63
Other Noncurrent Operating Liabilities	0.00	33	32	30	29
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	594	-891	-822	-738	-651
Total Preferred & Common Equity	594	-891	-822	-738	-651
Total Common Equity	594	-891	-822	-738	-651
Common Stock	0.00	11	29	53	81
Retained Earnings	0.00	-577	-541	-499	-446
Accumulated Other Comprehensive Income / (Loss)	-271	-325	-309	-293	-286

This table presents Embecta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	12/31/2022	3/31/2023	6/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025
Total Assets	1,050	1,197	1,210	1,252	1,218	1,200	1,268	1,150	1,120	1,157
Total Current Assets	581	762	756	788	720	710	781	667	643	682
Cash & Equivalents	292	385	346	317	299	300	275	210	209	231
Restricted Cash	-	-	-	-	-	6.70	6.70	6.70	3.00	3.00
Accounts Receivable	119	143	153	190	206	167	243	221	203	193
Inventories, net	130	143	158	170	149	153	186	169	169	190
Other Current Assets	39	90	100	110	65	83	70	61	59	65
Plant, Property, & Equipment, net	376	314	314	309	301	293	291	259	257	263
Total Noncurrent Assets	94	121	140	156	197	196	195	223	219	213
Goodwill	25	24	24	25	24	24	24	23	23	23
Noncurrent Deferred & Refundable Income Taxes	-	97	116	131	173	172	171	200	196	190
Total Liabilities & Shareholders' Equity	1,050	1,197	1,210	1,252	1,218	1,200	1,268	1,150	1,120	1,157
Total Liabilities	1,897	2,033	2,033	2,062	2,011	1,969	2,031	1,918	1,856	1,827
Total Current Liabilities	229	370	358	386	327	310	371	298	259	276
Short-Term Debt	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50	9.50
Accounts Payable	64	107	127	125	100	91	119	116	80	81
Accrued Expenses	90	157	147	160	122	120	142	127	123	129
Current Deferred & Payable Income Tax Liabilities	20	45	36	35	34	28	41	0.00	0.00	7.10
Current Employee Benefit Liabilities	41	49	36	52	57	59	56	43	44	45
Other Current Liabilities	3.60	3.60	3.60	3.60	3.70	3.70	3.40	3.40	3.40	3.40
Total Noncurrent Liabilities	1,669	1,663	1,675	1,676	1,685	1,659	1,661	1,620	1,597	1,551
Long-Term Debt	1,599	1,597	1,596	1,595	1,593	1,592	1,591	1,535	1,509	1,459
Noncurrent Deferred & Payable Income Tax Liabilities	37	33	47	49	61	36	39	56	59	64
Other Noncurrent Operating Liabilities	33	32	32	32	31	31	31	30	30	29
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-848	-836	-823	-809	-794	-770	-764	-769	-736	-670
Total Preferred & Common Equity	-848	-836	-823	-809	-794	-770	-764	-769	-736	-670
Total Common Equity	-848	-836	-823	-809	-794	-770	-764	-769	-736	-670
Common Stock	6.40	13	19	24	34	40	47	59	66	71
Retained Earnings	-556	-551	-545	-539	-530	-510	-504	-508	-494	-457
Accumulated Other Comprehensive Income / (Loss)	-298	-299	-296	-295	-298	-300	-306	-320	-308	-283

This table displays calculated financial ratios and metrics derived from Embecta's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	7.35%	-3.07%	-0.77%	0.21%	-3.80%
EBITDA Growth	0.00%	1.60%	-36.67%	-25.47%	-18.20%	47.55%
EBIT Growth	0.00%	1.73%	-38.82%	-29.76%	-26.42%	55.66%
NOPAT Growth	0.00%	-3.70%	-34.58%	-45.32%	100.29%	-42.65%
Net Income Growth	0.00%	-2.99%	-46.09%	-68.52%	11.22%	21.84%
EPS Growth	0.00%	-2.93%	-46.57%	-68.64%	9.84%	20.90%
Operating Cash Flow Growth	0.00%	-8.47%	-9.66%	-83.58%	-47.27%	436.97%
Free Cash Flow Firm Growth	0.00%	0.00%	363.17%	-83.79%	142.68%	12.93%
Invested Capital Growth	0.00%	0.00%	-35.17%	18.14%	23.53%	-7.70%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.66%	0.38%	-2.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	19.12%	-3.47%	14.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	21.96%	-6.34%	15.72%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	18.73%	43.18%	-4.01%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	49.15%	12.34%	14.11%
EPS Q/Q Growth	0.00%	0.00%	0.00%	48.78%	10.74%	14.08%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-6.25%	-29.55%	-7.75%	42.74%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	45.73%	27.98%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-4.71%	1.35%	-8.16%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	70.25%	68.69%	68.61%	66.91%	65.46%	62.64%
EBITDA Margin	48.35%	45.76%	29.90%	22.46%	18.33%	28.12%
Operating Margin	44.82%	42.22%	27.41%	19.76%	14.85%	22.41%
EBIT Margin	44.82%	42.47%	26.81%	18.98%	13.93%	22.55%
Profit (Net Income) Margin	39.39%	35.60%	19.80%	6.28%	6.97%	8.83%
Tax Burden Percent	88.02%	83.81%	87.14%	66.60%	177.15%	69.99%
Interest Burden Percent	99.86%	100.00%	84.74%	49.69%	28.24%	55.95%
Effective Tax Rate	11.98%	16.19%	12.86%	33.40%	-77.15%	30.01%
Return on Invested Capital (ROIC)	0.00%	138.77%	55.08%	35.10%	58.08%	31.34%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	47.85%	29.06%	41.23%	25.35%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-205.60%	-43.32%	-68.12%	-45.08%
Return on Equity (ROE)	0.00%	0.00%	-150.52%	-8.22%	-10.04%	-13.74%
Cash Return on Invested Capital (CROIC)	0.00%	-61.23%	97.75%	18.47%	37.03%	39.35%
Operating Return on Assets (OROA)	0.00%	62.80%	32.31%	18.49%	12.52%	20.50%
Return on Assets (ROA)	0.00%	52.64%	23.86%	6.12%	6.26%	8.03%
Return on Common Equity (ROCE)	0.00%	0.00%	-150.52%	-8.22%	-10.04%	-13.74%
Return on Equity Simple (ROE_SIMPLE)	0.00%	69.80%	-25.08%	-8.57%	-10.61%	0.00%
Net Operating Profit after Tax (NOPAT)	428	412	270	148	295	169
NOPAT Margin	39.45%	35.39%	23.89%	13.16%	26.31%	15.68%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	7.23%	6.04%	16.85%	6.00%
Return On Investment Capital (ROIC_SIMPLE)	-	-	37.67%	18.87%	35.32%	22.67%
Cost of Revenue to Revenue	29.75%	31.31%	31.39%	33.09%	34.54%	37.36%
SG&A Expenses to Revenue	19.78%	21.03%	30.06%	39.32%	43.59%	36.78%
R&D to Revenue	5.66%	5.43%	5.92%	7.60%	7.02%	3.45%
Operating Expenses to Revenue	25.44%	26.47%	41.20%	47.14%	50.61%	40.24%
Earnings before Interest and Taxes (EBIT)	487	495	303	213	157	244
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	525	533	338	252	206	304
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	1.37	0.73	0.72	0.76
Price to Earnings (P/E)	0.00	0.00	6.92	11.67	10.31	8.65
Dividend Yield	0.00%	0.00%	0.56%	4.18%	4.29%	4.25%
Earnings Yield	0.00%	0.00%	14.44%	8.57%	9.70%	11.56%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	7.33	4.61	3.75	3.84
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	2.50	1.87	1.88	1.85
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	8.37	8.34	10.24	6.57
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	9.33	9.87	13.47	8.19
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	10.47	14.23	7.13	11.77
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	6.85	31.00	59.05	10.41
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	5.90	27.03	11.19	9.38
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	-1.80	-1.95	-2.13	-2.15
Long-Term Debt to Equity	0.00	0.00	-1.79	-1.94	-2.12	-2.13
Financial Leverage	0.00	0.00	-4.30	-1.49	-1.65	-1.78
Leverage Ratio	0.00	1.33	-6.31	-1.34	-1.60	-1.71
Compound Leverage Factor	0.00	1.33	-5.35	-0.67	-0.45	-0.96
Debt to Total Capital	0.00%	0.00%	224.46%	205.12%	188.26%	187.03%
Short-Term Debt to Total Capital	0.00%	0.00%	1.33%	1.22%	1.14%	1.27%
Long-Term Debt to Total Capital	0.00%	0.00%	223.14%	203.90%	187.12%	185.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	-124.46%	-105.12%	-88.26%	-87.03%
Debt to EBITDA	0.00	0.00	4.76	6.37	7.65	4.60
Net Debt to EBITDA	0.00	0.00	3.78	5.07	6.32	3.85
Long-Term Debt to EBITDA	0.00	0.00	4.73	6.33	7.60	4.57
Debt to NOPAT	0.00	0.00	5.96	10.87	5.33	8.25
Net Debt to NOPAT	0.00	0.00	4.73	8.66	4.40	6.90
Long-Term Debt to NOPAT	0.00	0.00	5.92	10.80	5.30	8.20
Altman Z-Score	0.00	0.00	2.09	1.51	1.33	1.85
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.78	2.21	2.12	2.03	2.41
Quick Ratio	0.00	0.92	1.54	1.37	1.38	1.43
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-182	479	78	188	213
Operating Cash Flow to CapEx	1,189.74%	1,239.95%	1,746.61%	255.47%	225.95%	2,061.29%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	1.48	1.21	0.97	0.90	0.91
Accounts Receivable Turnover	0.00	7.74	7.96	7.67	5.53	5.46
Inventory Turnover	0.00	3.09	2.95	2.70	2.40	2.31
Fixed Asset Turnover	0.00	2.58	3.00	3.72	3.80	3.95
Accounts Payable Turnover	0.00	6.73	4.38	3.16	2.98	3.60
Days Sales Outstanding (DSO)	0.00	47.17	45.84	47.58	65.96	66.84
Days Inventory Outstanding (DIO)	0.00	118.03	123.93	135.26	152.25	158.31
Days Payable Outstanding (DPO)	0.00	54.21	83.43	115.38	122.37	101.29
Cash Conversion Cycle (CCC)	0.00	110.99	86.34	67.46	95.83	123.86
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	594	385	455	562	519
Invested Capital Turnover	0.00	3.92	2.31	2.67	2.21	2.00
Increase / (Decrease) in Invested Capital	0.00	594	-209	70	107	-43
Enterprise Value (EV)	0.00	0.00	2,825	2,099	2,108	1,995
Market Capitalization	0.00	0.00	1,548	822	807	825
Book Value per Share	$0.00	$0.00	($15.41)	($14.34)	($12.80)	($11.12)
Tangible Book Value per Share	$0.00	$0.00	($15.84)	($14.77)	($13.21)	($11.51)
Total Capital	0.00	594	716	782	837	748
Total Debt	0.00	0.00	1,608	1,603	1,575	1,398
Total Long-Term Debt	0.00	0.00	1,598	1,594	1,565	1,389
Net Debt	0.00	0.00	1,277	1,277	1,301	1,170
Capital Expenditures (CapEx)	42	37	24	27	16	9.30
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	128	42	79	122	151
Debt-free Net Working Capital (DFNWC)	0.00	128	373	405	397	379
Net Working Capital (NWC)	0.00	128	364	396	387	370
Net Nonoperating Expense (NNE)	0.62	-2.43	46	77	217	74
Net Nonoperating Obligations (NNO)	0.00	0.00	1,277	1,277	1,301	1,170
Total Depreciation and Amortization (D&A)	38	38	35	39	49	60
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	10.97%	3.75%	7.01%	10.89%	13.96%
Debt-free Net Working Capital to Revenue	0.00%	10.97%	33.04%	36.14%	35.30%	35.12%
Net Working Capital to Revenue	0.00%	10.97%	32.20%	35.30%	34.46%	34.24%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$3.92	$1.23	$1.36	$1.64
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	57.07M	57.33M	58.13M	58.51M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$3.89	$1.22	$1.34	$1.62
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	57.07M	57.33M	58.13M	58.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	57.07M	57.33M	58.13M	58.51M
Normalized Net Operating Profit after Tax (NOPAT)	428	412	321	149	117	169
Normalized NOPAT Margin	39.45%	35.39%	28.43%	13.31%	10.40%	15.68%
Pre Tax Income Margin	44.75%	42.47%	22.72%	9.43%	3.94%	12.62%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	3.85%	48.86%	44.06%	36.69%
Augmented Payout Ratio	0.00%	0.00%	3.85%	48.86%	44.06%	36.69%

This table displays calculated financial ratios and metrics derived from Embecta's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.95%	-1.72%	2.66%	0.58%	3.64%	-4.75%	1.49%	-5.55%	-9.82%	8.44%	-7.72%
EBITDA Growth	-42.33%	-45.38%	1,303.23%	-41.66%	-18.72%	18.84%	-17.01%	-21.97%	53.94%	67.41%	103.32%
EBIT Growth	-48.08%	-49.41%	671.93%	-48.59%	-26.51%	16.35%	-32.52%	-35.24%	65.78%	80.29%	150.45%
NOPAT Growth	-62.10%	-52.88%	1,574.29%	14.78%	260.17%	-21.55%	-40.76%	-68.59%	-63.92%	94.64%	180.45%
Net Income Growth	-82.41%	-75.64%	134.88%	-42.90%	106.43%	-3.29%	143.33%	-100.00%	-18.69%	209.52%	80.82%
EPS Growth	-82.61%	-75.70%	137.93%	-42.62%	108.33%	-3.85%	118.18%	-100.00%	-20.00%	212.00%	83.33%
Operating Cash Flow Growth	-107.12%	-128.35%	-48.97%	-121.69%	286.92%	77.42%	-10.14%	59.54%	30.86%	3,966.67%	215.79%
Free Cash Flow Firm Growth	0.00%	107.74%	0.00%	81.51%	106.36%	-256.10%	-127.94%	53.38%	-114.03%	204.87%	206.73%
Invested Capital Growth	0.00%	1.90%	18.14%	32.42%	20.32%	16.14%	23.53%	9.51%	8.55%	1.86%	-7.70%
Revenue Q/Q Growth	0.51%	3.25%	-1.47%	-1.63%	3.57%	-5.12%	4.99%	-8.46%	-1.11%	14.09%	-10.66%
EBITDA Q/Q Growth	-32.71%	-6.73%	-23.42%	21.38%	-6.25%	36.36%	-46.52%	14.13%	84.95%	48.29%	-35.04%
EBIT Q/Q Growth	-37.21%	-8.19%	-30.79%	28.83%	-10.24%	45.36%	-59.85%	23.64%	129.78%	58.08%	-44.23%
NOPAT Q/Q Growth	-42.98%	22.10%	-20.19%	106.57%	78.93%	-73.40%	-39.74%	9.54%	105.52%	43.47%	-13.17%
Net Income Q/Q Growth	-60.23%	8.57%	-60.53%	235.00%	43.78%	-49.13%	-0.68%	-100.00%	0.00%	93.62%	-41.98%
EPS Q/Q Growth	-60.66%	8.33%	-57.69%	218.18%	42.86%	-50.00%	-4.00%	-100.00%	0.00%	95.00%	-43.59%
Operating Cash Flow Q/Q Growth	-121.52%	28.46%	418.28%	-144.26%	285.50%	-108.64%	1,366.67%	-119.92%	700.00%	155.35%	3.45%
Free Cash Flow Firm Q/Q Growth	-22.80%	107.39%	-230.26%	-56.51%	142.22%	-281.35%	-90.20%	67.99%	87.29%	1,455.29%	93.58%
Invested Capital Q/Q Growth	13.29%	9.44%	-4.71%	12.08%	2.94%	5.64%	1.35%	-0.64%	2.04%	-0.88%	-8.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.50%	66.24%	64.49%	67.04%	64.55%	69.76%	60.75%	59.98%	63.36%	66.70%	60.04%
EBITDA Margin	21.98%	19.85%	15.43%	19.04%	17.24%	24.77%	12.62%	15.73%	29.42%	38.24%	27.80%
Operating Margin	20.07%	17.93%	9.15%	16.41%	13.65%	20.51%	9.16%	10.96%	24.29%	31.81%	21.40%
EBIT Margin	18.51%	16.46%	11.56%	15.15%	13.13%	20.11%	7.69%	10.39%	24.13%	33.43%	20.87%
Profit (Net Income) Margin	5.05%	5.31%	2.13%	7.25%	10.06%	5.39%	5.10%	0.00%	9.07%	15.40%	10.00%
Tax Burden Percent	57.14%	75.62%	120.00%	140.56%	291.92%	54.44%	-208.57%	0.00%	65.64%	63.02%	91.03%
Interest Burden Percent	47.76%	42.68%	15.34%	34.05%	26.26%	49.27%	-31.82%	-2.57%	57.28%	73.08%	52.63%
Effective Tax Rate	42.86%	24.38%	-20.00%	-40.56%	-191.92%	45.56%	0.00%	0.00%	34.36%	36.98%	8.97%
Return on Invested Capital (ROIC)	58.76%	31.90%	29.29%	57.81%	93.84%	24.21%	14.15%	15.90%	31.42%	39.47%	38.93%
ROIC Less NNEP Spread (ROIC-NNEP)	55.94%	30.09%	27.34%	54.34%	87.14%	23.00%	13.86%	14.37%	30.06%	38.39%	36.91%
Return on Net Nonoperating Assets (RNNOA)	-85.62%	-47.28%	-40.75%	-84.20%	-139.78%	-38.09%	-22.90%	-24.20%	-51.92%	-68.39%	-65.64%
Return on Equity (ROE)	-26.86%	-15.38%	-11.46%	-26.39%	-45.94%	-13.89%	-8.75%	-8.31%	-20.49%	-28.92%	-26.71%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	18.47%	6.55%	29.47%	25.04%	37.03%	46.87%	22.19%	29.69%	39.35%
Operating Return on Assets (OROA)	17.11%	15.93%	11.27%	14.08%	12.34%	17.86%	6.91%	9.72%	22.46%	30.40%	18.98%
Return on Assets (ROA)	4.67%	5.14%	2.07%	6.74%	9.46%	4.79%	4.59%	0.00%	8.44%	14.00%	9.09%
Return on Common Equity (ROCE)	-26.86%	-15.38%	-11.46%	-26.39%	-45.94%	-13.89%	-8.75%	-8.31%	-20.49%	-28.92%	-26.71%
Return on Equity Simple (ROE_SIMPLE)	-11.48%	-5.83%	0.00%	-6.97%	-9.12%	-9.13%	0.00%	-7.57%	-7.17%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	32	39	31	64	114	30	18	20	41	59	51
NOPAT Margin	11.47%	13.56%	10.98%	23.06%	39.84%	11.17%	6.41%	7.67%	15.94%	20.05%	19.48%
Net Nonoperating Expense Percent (NNEP)	2.82%	1.81%	1.95%	3.47%	6.70%	1.21%	0.29%	1.53%	1.37%	1.08%	2.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	3.96%	7.91%	-	-	2.19%	2.59%	5.28%	7.42%	6.88%
Cost of Revenue to Revenue	31.50%	33.76%	35.51%	32.96%	35.45%	30.24%	39.25%	40.02%	36.64%	33.30%	39.96%
SG&A Expenses to Revenue	40.45%	40.41%	46.08%	43.35%	44.50%	41.76%	44.67%	41.28%	35.98%	33.40%	36.89%
R&D to Revenue	7.98%	7.90%	8.37%	7.28%	6.41%	7.49%	6.92%	7.75%	3.09%	1.49%	1.74%
Operating Expenses to Revenue	48.43%	48.30%	55.34%	50.63%	50.91%	49.25%	51.59%	49.03%	39.07%	34.89%	38.64%
Earnings before Interest and Taxes (EBIT)	51	47	33	42	38	55	22	27	63	99	55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	61	57	44	53	50	68	36	41	76	113	73
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.38	1.07	0.73	0.93	0.67	0.64	0.72	1.08	0.69	0.51	0.76
Price to Earnings (P/E)	16.32	25.22	11.67	18.84	10.76	10.34	10.31	20.63	14.04	6.77	8.65
Dividend Yield	1.67%	2.89%	4.18%	4.12%	4.57%	4.80%	4.29%	2.91%	4.71%	6.19%	4.25%
Earnings Yield	6.13%	3.96%	8.57%	5.31%	9.29%	9.67%	9.70%	4.85%	7.12%	14.76%	11.56%
Enterprise Value to Invested Capital (EV/IC)	6.42	5.19	4.61	4.60	3.90	3.68	3.75	4.52	3.59	3.19	3.84
Enterprise Value to Revenue (EV/Rev)	2.50	2.23	1.87	2.09	1.81	1.82	1.88	2.28	1.90	1.63	1.85
Enterprise Value to EBITDA (EV/EBITDA)	10.83	11.73	8.34	10.96	10.12	9.56	10.24	13.01	9.26	6.76	6.57
Enterprise Value to EBIT (EV/EBIT)	12.70	14.21	9.87	13.56	12.86	12.20	13.47	17.84	12.30	8.56	8.19
Enterprise Value to NOPAT (EV/NOPAT)	15.76	19.94	14.23	15.21	8.90	9.88	7.13	8.46	12.30	10.20	11.77
Enterprise Value to Operating Cash Flow (EV/OCF)	20.26	25.78	31.00	0.00	65.08	52.70	59.05	58.11	40.15	13.41	10.41
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	27.03	80.01	14.47	15.78	11.19	10.09	16.85	10.83	9.38
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.95	-1.98	-1.95	-2.02	-2.08	-2.10	-2.13	-2.01	-2.06	-2.19	-2.15
Long-Term Debt to Equity	-1.94	-1.97	-1.94	-2.01	-2.07	-2.08	-2.12	-2.00	-2.05	-2.18	-2.13
Financial Leverage	-1.53	-1.57	-1.49	-1.55	-1.60	-1.66	-1.65	-1.68	-1.73	-1.78	-1.78
Leverage Ratio	-1.47	-1.39	-1.34	-1.48	-1.51	-1.60	-1.60	-1.52	-1.54	-1.69	-1.71
Compound Leverage Factor	-0.70	-0.59	-0.21	-0.50	-0.40	-0.79	0.51	0.04	-0.88	-1.24	-0.90
Debt to Total Capital	205.07%	201.80%	205.12%	198.10%	192.53%	191.29%	188.26%	199.15%	194.10%	183.84%	187.03%
Short-Term Debt to Total Capital	1.21%	1.19%	1.22%	1.17%	1.14%	1.14%	1.14%	1.23%	1.21%	1.19%	1.27%
Long-Term Debt to Total Capital	203.86%	200.60%	203.90%	196.92%	191.39%	190.15%	187.12%	197.92%	192.88%	182.65%	185.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-105.07%	-101.80%	-105.12%	-98.10%	-92.53%	-91.29%	-88.26%	-99.15%	-94.10%	-83.84%	-87.03%
Debt to EBITDA	6.21	7.59	6.37	7.49	7.90	7.50	7.65	7.95	6.87	5.51	4.60
Net Debt to EBITDA	4.87	6.09	5.07	6.09	6.39	6.18	6.32	6.83	5.91	4.63	3.85
Long-Term Debt to EBITDA	6.17	7.55	6.33	7.44	7.86	7.46	7.60	7.90	6.83	5.47	4.57
Debt to NOPAT	9.04	12.91	10.87	10.39	6.95	7.75	5.33	5.17	9.12	8.32	8.25
Net Debt to NOPAT	7.09	10.36	8.66	8.45	5.62	6.39	4.40	4.44	7.85	6.99	6.90
Long-Term Debt to NOPAT	8.98	12.84	10.80	10.33	6.91	7.71	5.30	5.13	9.07	8.26	8.20
Altman Z-Score	1.28	1.14	1.02	1.12	1.08	1.07	0.99	1.18	1.18	1.29	1.28
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.11	2.04	2.12	2.20	2.29	2.11	2.03	2.24	2.48	2.47	2.41
Quick Ratio	1.40	1.32	1.37	1.55	1.50	1.40	1.38	1.44	1.59	1.54	1.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-405	30	-39	-61	26	-47	-89	-28	-3.61	49	95
Operating Cash Flow to CapEx	-224.14%	-136.76%	321.74%	-485.19%	714.71%	-21.65%	0.00%	-353.33%	31,800.00%	20,300.00%	1,150.68%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.92	0.97	0.97	0.93	0.94	0.89	0.90	0.94	0.93	0.91	0.91
Accounts Receivable Turnover	7.32	7.20	7.67	6.42	7.08	5.16	5.53	5.19	5.84	5.05	5.46
Inventory Turnover	2.28	2.45	2.70	2.57	2.51	2.11	2.40	2.52	2.45	2.19	2.31
Fixed Asset Turnover	3.57	3.25	3.72	3.65	3.73	3.73	3.80	3.95	3.92	3.98	3.95
Accounts Payable Turnover	2.84	3.90	3.16	3.63	3.58	3.09	2.98	3.73	4.62	4.11	3.60
Days Sales Outstanding (DSO)	49.83	50.69	47.58	56.86	51.52	70.71	65.96	70.33	62.48	72.22	66.84
Days Inventory Outstanding (DIO)	159.74	148.87	135.26	142.25	145.48	172.88	152.25	144.75	149.18	166.98	158.31
Days Payable Outstanding (DPO)	128.53	93.60	115.38	100.44	101.99	118.14	122.37	97.91	78.94	88.89	101.29
Cash Conversion Cycle (CCC)	81.05	105.96	67.46	98.67	95.00	125.45	95.83	117.18	132.73	150.31	123.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	437	478	455	510	525	555	562	559	570	565	519
Invested Capital Turnover	5.12	2.35	2.67	2.51	2.36	2.17	2.21	2.07	1.97	1.97	2.00
Increase / (Decrease) in Invested Capital	437	8.90	70	125	89	77	107	49	45	10	-43
Enterprise Value (EV)	2,800	2,478	2,099	2,346	2,050	2,039	2,108	2,528	2,048	1,801	1,995
Market Capitalization	1,541	1,191	822	1,042	755	721	807	1,200	741	566	825
Book Value per Share	($14.36)	($14.13)	($14.34)	($13.78)	($13.37)	($13.24)	($12.80)	($13.23)	($12.66)	($11.46)	($11.12)
Tangible Book Value per Share	($14.78)	($14.56)	($14.77)	($14.20)	($13.78)	($13.66)	($13.21)	($13.63)	($13.06)	($11.85)	($11.51)
Total Capital	783	795	782	809	832	837	837	775	782	799	748
Total Debt	1,606	1,605	1,603	1,602	1,601	1,600	1,575	1,544	1,519	1,468	1,398
Total Long-Term Debt	1,596	1,595	1,594	1,593	1,592	1,591	1,565	1,535	1,509	1,459	1,389
Net Debt	1,259	1,287	1,277	1,304	1,295	1,319	1,301	1,328	1,306	1,235	1,170
Capital Expenditures (CapEx)	5.80	6.80	9.20	2.70	3.40	9.70	0.00	1.50	0.10	0.40	7.30
Debt-free, Cash-free Net Working Capital (DFCFNWC)	62	94	79	104	103	138	122	162	181	182	151
Debt-free Net Working Capital (DFNWC)	408	411	405	402	409	420	397	379	394	416	379
Net Working Capital (NWC)	399	402	396	393	400	410	387	369	384	406	370
Net Nonoperating Expense (NNE)	18	24	25	44	86	16	3.74	20	18	14	25
Net Nonoperating Obligations (NNO)	1,259	1,287	1,277	1,304	1,295	1,319	1,301	1,328	1,306	1,235	1,170
Total Depreciation and Amortization (D&A)	9.60	9.70	11	11	12	13	14	14	14	14	18
Debt-free, Cash-free Net Working Capital to Revenue	5.52%	8.42%	7.01%	9.24%	9.06%	12.34%	10.89%	14.61%	16.79%	16.50%	13.96%
Debt-free Net Working Capital to Revenue	36.49%	36.93%	36.14%	35.85%	36.12%	37.53%	35.30%	34.17%	36.46%	37.69%	35.12%
Net Working Capital to Revenue	35.64%	36.08%	35.30%	35.01%	35.28%	36.68%	34.46%	33.31%	35.58%	36.83%	34.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.24	$0.27	$0.10	$0.35	$0.50	$0.25	$0.26	$0.00	$0.40	$0.78	$0.46
Adjusted Weighted Average Basic Shares Outstanding	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M	58.49M	58.51M
Adjusted Diluted Earnings per Share	$0.24	$0.26	$0.11	$0.35	$0.50	$0.25	$0.24	$0.00	$0.40	$0.78	$0.44
Adjusted Weighted Average Diluted Shares Outstanding	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M	58.49M	58.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.29M	57.30M	57.33M	57.58M	57.67M	57.70M	58.13M	58.13M	58.44M	58.49M	58.51M
Normalized Net Operating Profit after Tax (NOPAT)	32	39	18	32	27	30	18	20	41	59	51
Normalized NOPAT Margin	11.47%	13.56%	6.41%	11.49%	9.55%	11.17%	6.41%	7.67%	15.94%	20.05%	19.48%
Pre Tax Income Margin	8.84%	7.03%	1.77%	5.16%	3.45%	9.91%	-2.45%	-0.27%	13.82%	24.43%	10.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	27.33%	72.88%	48.86%	77.76%	49.00%	49.35%	44.06%	59.62%	65.91%	41.75%	36.69%
Augmented Payout Ratio	27.33%	72.88%	48.86%	77.76%	49.00%	49.35%	44.06%	59.62%	65.91%	41.75%	36.69%

Financials Breakdown Chart

Key Financial Trends

Embecta Corp. (EMBC) has delivered a largely steady top line with improving cash flow in late 2025, but the company carries a sizable balance-sheet burden from debt and negative equity. Here are the most relevant takeaways from the last four years of quarterly reports:

Stable revenue with solid gross margins. Operating revenue has ranged roughly from $259M to $296M in recent quarters, and gross margin has hovered in the ~60%–66% band, peaking in Q3 2025 (~66.7%).
Strong profitability in late 2025. In Q3 2025, net income from continuing operations was about $45.5M with basic EPS of $0.78; Q4 2025 net income was about $26.4M with EPS around $0.46, signaling continued profitability through the period.
Operating cash flow improving in late 2025. Net cash from continuing operating activities was approximately $84.0M in Q4 2025 and about $81.2M in Q3 2025, suggesting stronger cash generation vs earlier quarters.
Modest capital spending supports cash conversion. Quarterly capex is relatively small, e.g., Purchase of PP&E around $7.3M in Q4 2025 and around $0.4M in Q3 2025, indicating limited ongoing capital needs.
Reasonable near-term liquidity in cash terms. Cash and cash equivalents have generally sat in the $210M–$231M range in recent reporting periods, providing a liquidity cushion despite leverage.
Revenue volatility/seasonality. Quarter-to-quarter revenue swings of several tens of millions suggest seasonality or cyclical factors rather than a consistent growth trajectory.
Gross margin trajectory shows some variability. While margins run in a healthy range, there isn’t a clear, sustained YoY margin expansion across the four-year window.
Negative equity and very high debt load. In recent quarters, Total Equity is negative (e.g., about -$669.6M in Q3 2025) and Long-Term Debt sits around $1.46–$1.59B, signaling meaningful balance-sheet stress.
Debt and financing outflows weigh on cash flow. Net cash from financing activities has been consistently negative across many quarters due to debt repayments and dividends, contributing to net cash outflows in several periods.
Earnings volatility with a quarter of zero earnings. Notably, some periods show minimal or zero net income (e.g., Q1 2025), highlighting variability in quarterly profitability against a generally steady top line.

05/05/26 05:46 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Embecta's Financials

When does Embecta's financial year end?

According to the most recent income statement we have on file, Embecta's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

How has Embecta's net income changed over the last 5 years?

Embecta's net income appears to be on a downward trend, with a most recent value of $95.40 million in 2025, falling from $427.60 million in 2020. The previous period was $78.30 million in 2024. Check out Embecta's forecast to explore projected trends and price targets.

What is Embecta's operating income?

Embecta's total operating income in 2025 was $242.10 million, based on the following breakdown:

Total Gross Profit: $676.80 million
Total Operating Expenses: $434.70 million

How has Embecta's revenue changed over the last 5 years?

Over the last 5 years, Embecta's total revenue changed from $1.09 billion in 2020 to $1.08 billion in 2025, a change of -0.5%.

How much debt does Embecta have?

Embecta's total liabilities were at $1.74 billion at the end of 2025, a 13.9% decrease from 2024, and a 799.1% increase since 2021.

How much cash does Embecta have?

In the past 4 years, Embecta's cash and equivalents has ranged from $0.00 in 2021 to $330.90 million in 2022, and is currently $225.50 million as of their latest financial filing in 2025.

How has Embecta's book value per share changed over the last 5 years?

Over the last 5 years, Embecta's book value per share changed from 0.00 in 2020 to -11.12 in 2025, a change of -1,112.4%.

Related Companies

Financial statements for NASDAQ:EMBC last updated on 11/28/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Embecta (EMBC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Embecta's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Embecta (EMBC) Financials

Annual Income Statements for Embecta

Quarterly Income Statements for Embecta

Annual Cash Flow Statements for Embecta

Quarterly Cash Flow Statements for Embecta

Annual Balance Sheets for Embecta

Quarterly Balance Sheets for Embecta

Annual Metrics And Ratios for Embecta

Quarterly Metrics And Ratios for Embecta

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Embecta's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools